WHO Approves World’s First Diagnostic Test for MPox
The World Health Organization (WHO) has taken a critical step in improving global access to MPox testing by listing the ...
FDA Approves Miplyffa: First-Ever Drug for Niemann-Pick Disease, Type C (NPC)
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved Miplyffa (arimoclomol), a groundbreaking treatment for Niemann-Pick disease, ...
MPOX Virus Truths: Is It a Real Public Health Threat or a Hoax?
The World Health Organization (WHO) has labeled the multi-country outbreak of Mpox a public health emergency, raising concerns worldwide. Given ...
Underground Demand: India’s Rich Seek Elusive Weight-Loss Drugs
As global demand for weight-loss drugs like Ozempic and Mounjaro surges, affluent Indians are going to great lengths to secure ...
FDA Approves New Treatment Option for HER2-Positive Cancers
The United States Food and Drug Administration (FDA) has approved a new medicine called trastuzumab-strf (HLX02, brand name Hercessi). This ...
FDA Approves Pivya (pivmecillinam)Tablets for Uncomplicated Urinary Tract Infections
In a recent landmark decision, the U.S. Food and Drug Administration (FDA) has granted approval to Pivya (pivmecillinam) tablets for ...
Shortage of Weight Loss Drugs Zepbound and Wegovy Leaves Patients Seeking Alternatives
As the demand for weight loss medications surges, a shortage of supply has hit the market, leaving patients struggling to ...
Milestone Moment: FDA Greenlights Gene Therapy for Childhood Leukodystrophy
In a historic move, the U.S. Food and Drug Administration (FDA) has approved the first-ever gene therapy named Lenmeldy (atidarsagene ...
FDA Approves First-Ever Treatment for Heart Problems in Overweight Adults
Exciting News: On March 08, 2024, the U.S. Food and Drug Administration (FDA) gave the green light for Wegovy (semaglutide) ...